Codex Capital Asset Management »

Vertex Pharmaceuticals Incorporated shares owned by Codex Capital Asset Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Codex Capital Asset Management from 13F filings

Historical chart of Codex Capital Asset Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Codex Capital Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Codex Capital Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.5M 12k 465.08
2024-06-30 $5.5M 12k 468.72

More positions owned by Codex Capital Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
General Electric Com New (GE)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Thermo Fisher Scientific (TMO)
Mastercard Incorporated Cl A (MA)
Merck & Co (MRK)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Regeneron Pharmaceuticals (REGN)
JPMorgan Chase & Co. (JPM)

View all positions for Codex Capital Asset Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
Amundi
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation

View all funds holding Vertex Pharmaceuticals Incorporated